Clarke Barlow
Follow
Get notifications in MyBN when activity occurs.
Clarke Barlow
Client Advisor & Investment Manager / Alto Capital
Clarke Barlow is a financial advisor with over 22 years of experience in the financial services industry within Australia and the UK.
Since 2007, Mr Barlow has provided corporate advisory services to ASX-listed companies across a variety of industries, with a focus on growth opportunities, providing them with advice on business models & strategy, structuring of pre-IPO and IPO fund raisings, reverse takeovers, capital raisings, M&A, investor relations and capital markets advice.
Mr Barlow is a founder and director of AMG Acquisition Corp, a public-listed company on the Toronto Venture Exchange.
He holds a Bachelor of Commerce from the University of Western Australia, has Level 2 ASX derivatives accreditation, and is a member of the Australian Institute of Company Directors.
Since 2007, Mr Barlow has provided corporate advisory services to ASX-listed companies across a variety of industries, with a focus on growth opportunities, providing them with advice on business models & strategy, structuring of pre-IPO and IPO fund raisings, reverse takeovers, capital raisings, M&A, investor relations and capital markets advice.
Mr Barlow is a founder and director of AMG Acquisition Corp, a public-listed company on the Toronto Venture Exchange.
He holds a Bachelor of Commerce from the University of Western Australia, has Level 2 ASX derivatives accreditation, and is a member of the Australian Institute of Company Directors.
Lists and Charts
Total Shareholder Return as at 31/10/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 1428th | NeuroScientific Biopharmaceuticals | -42% | -31% |
1740 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Roles
Year started and most recent title
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | NeuroScientific Biopharmaceuticals | $2.2m |
198 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Person Activity
| NEWS: Tagged in Board Moves November 17, 2023 | 17 Nov 2023 |
| NEW ROLE: Client Advisor & Investment Manager, Alto Capital | 17 Nov 2023 |
| NEW ROLE: Non-Executive Director, Tryptamine Therapeutics | 17 Nov 2023 |
| NEW ROLE: Non-Executive Director, NeuroScientific Biopharmaceuticals | 17 Nov 2023 |
